Wang M - Search Results

1

Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.

Zhou D, Yue D, Zhang Z, Tian P, Feng Y, Liu Z, Zhang B, Wang M, Zhao X, Wang C. Zhou D, et al. Among authors: wang m, wang c. World J Surg Oncol. 2022 Jul 1;20(1):222. doi: 10.1186/s12957-022-02689-w. World J Surg Oncol. 2022. PMID: 35778770 Free PMC article.

2

Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?

Wang M, Zhao J, Pan Y, Su YJ, You J, Zhao XL, Wang CL. Wang M, et al. Among authors: wang cl. World J Surg. 2009 Mar;33(3):497-504. doi: 10.1007/s00268-008-9859-3. World J Surg. 2009. PMID: 19115028

3

Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer.

Wang M, Zhao J, Su YJ, Zhao XL, Wang CL. Wang M, et al. Among authors: wang cl. Oncol Lett. 2012 Dec;4(6):1349-1353. doi: 10.3892/ol.2012.892. Epub 2012 Sep 3. Oncol Lett. 2012. PMID: 23226806 Free PMC article.

4

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines.

Yue D, Gong L, You J, Su Y, Zhang Z, Zhang Z, Gu F, Wang M, Wang C. Yue D, et al. Among authors: wang m, wang c. BMC Cancer. 2014 Jun 10;14:422. doi: 10.1186/1471-2407-14-422. BMC Cancer. 2014. PMID: 24915848 Free PMC article.

5

Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.

Zhao X, Su Y, You J, Gong L, Zhang Z, Wang M, Zhao Z, Zhang Z, Li X, Wang C. Zhao X, et al. Among authors: wang m, wang c. Oncotarget. 2016 Sep 20;7(38):62619-62626. doi: 10.18632/oncotarget.11547. Oncotarget. 2016. PMID: 27566586 Free PMC article. Clinical Trial.

6

[Efficacy of adjuvant chemotherapy after left pneumonectomy on non-small cell lung cancer].

Wang M, Wang CL, Gong LQ, Gu F, Su YJ, You J. Wang M, et al. Among authors: wang cl. Ai Zheng. 2007 Dec;26(12):1365-8. Ai Zheng. 2007. PMID: 18076803 Free article. Chinese.

7

Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer.

Wang M, Zhao J, Zhang LM, Li H, Yu JP, Ren XB, Wang CL. Wang M, et al. Among authors: wang cl. J Cancer Res Clin Oncol. 2012 Dec;138(12):2069-77. doi: 10.1007/s00432-012-1291-2. Epub 2012 Jul 22. J Cancer Res Clin Oncol. 2012. PMID: 22821179

8

The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis.

Wang C, Su Y, Zhang L, Wang M, You J, Zhao X, Zhang Z, Liu J, Hao X. Wang C, et al. Among authors: wang m. PLoS One. 2012;7(9):e38046. doi: 10.1371/journal.pone.0038046. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049725 Free PMC article.

9

[Cetuximab in combination with icotinib overcomes the acquired resistance caused by EGFR T790M mutation in non-small cell lung cancer].

Wang M, Zhang L, Zhao X, Liu J, Chen Y, Wang C. Wang M, et al. Among authors: wang c. Zhonghua Zhong Liu Za Zhi. 2014 Sep;36(9):651-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25564053 Chinese.

10

Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC.

Zhao X, Wen X, Wei W, Su Y, You J, Gong L, Zhang Z, Wang M, Xiao J, Wei X, Wang C. Zhao X, et al. Among authors: wang m, wang c. Cancer Biomark. 2017 Dec 12;21(1):169-177. doi: 10.3233/CBM-170565. Cancer Biomark. 2017. PMID: 29036790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,955 results

Search Page

Filters